Global X Health Care Covered Call & Growth ETF
HYLG
HYLG was delisted on the 14th of February, 2025.
3 hedge funds and large institutions have $284K invested in Global X Health Care Covered Call & Growth ETF in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
6% less capital invested
Capital invested by funds: $302K → $284K (-$18.7K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.49K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$2.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$708 |
HYLG Hedge Fund Activity: Q4 2024 in Review
3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Global X Health Care Covered Call & Growth ETF (HYLG) for Q4 2024, worth a combined $284K — down 6.2% from $302K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HYLG and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Royal Bank of Canada, adding an estimated $9.49K. The largest seller was UBS Group, exiting entirely with an estimated $708 sold.
- 3 institutional investors held Global X Health Care Covered Call & Growth ETF (HYLG) as of Q4 2024, down from 4 in Q3 2024.
- Funds reported $284K of Global X Health Care Covered Call & Growth ETF stock for Q4 2024, down 6.2% quarter-over-quarter.
- 0 funds opened new Global X Health Care Covered Call & Growth ETF positions in Q4 2024 and 1 closed out, a net change of -1 holder.
- The largest Global X Health Care Covered Call & Growth ETF buyer in Q4 2024 was Royal Bank of Canada, an estimated $9.49K added.
- The largest Global X Health Care Covered Call & Growth ETF seller in Q4 2024 was UBS Group, an estimated $708 sold.
Based on aggregated 13F filings for Q4 2024.